Companion Animal Pharmaceuticals Market Research Report by Indication (Behavioral Disorders, Dermatologic Diseases, and Infectious Diseases), by Animal Type (Cats, Dogs, and Horses), by Distribution Channel, by Region (Americas, Asia-Pacific, and Europe,

Companion Animal Pharmaceuticals Market Research Report by Indication (Behavioral Disorders, Dermatologic Diseases, and Infectious Diseases), by Animal Type (Cats, Dogs, and Horses), by Distribution Channel, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Companion Animal Pharmaceuticals Market size was estimated at USD 11.26 billion in 2020 and expected to reach USD 12.29 billion in 2021, at a CAGR 9.50% to reach USD 19.42 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Companion Animal Pharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Indication, the market was studied across Behavioral Disorders, Dermatologic Diseases, Infectious Diseases, Orthopedic Diseases, and Pain.

Based on Animal Type, the market was studied across Cats, Dogs, and Horses.

Based on Distribution Channel, the market was studied across Retail Pharmacies, Veterinary Clinics, and Veterinary Hospitals.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Animal Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Companion Animal Pharmaceuticals Market, including Ashish Life Science Pvt. Ltd., Boehringer Ingelheim GmbH, Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals plc, Eco Animal Health Group plc, Elanco Animal Health Incorporated, Endovac Animal Health, Hipra, Indian Immunologicals Ltd., Inovet, Kyoritsu Seiyaku, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Holdings Limited, Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac, Zoetis Inc., and Zydus Animal Health and Investments Limited.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Companion Animal Pharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Companion Animal Pharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Companion Animal Pharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Companion Animal Pharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Companion Animal Pharmaceuticals Market?
6. What is the market share of the leading vendors in the Global Companion Animal Pharmaceuticals Market?
7. What modes and strategic moves are considered suitable for entering the Global Companion Animal Pharmaceuticals Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing prevalence of zoonotic diseases
5.2.2. Rising availability and adoption of pet health insurance
5.2.3. Rising initiatives by government and private organisation to promote animal health
5.3. Restraints
5.3.1. High storage cost for vaccines
5.4. Opportunities
5.4.1. Rising development of new drugs
5.4.2. Growing investment by key players
5.5. Challenges
5.5.1. Stringent regulations associated with the approval for drugs
6. Companion Animal Pharmaceuticals Market, by Indication
6.1. Introduction
6.2. Behavioral Disorders
6.3. Dermatologic Diseases
6.4. Infectious Diseases
6.5. Orthopedic Diseases
6.6. Pain
7. Companion Animal Pharmaceuticals Market, by Animal Type
7.1. Introduction
7.2. Cats
7.3. Dogs
7.4. Horses
8. Companion Animal Pharmaceuticals Market, by Distribution Channel
8.1. Introduction
8.2. Retail Pharmacies
8.3. Veterinary Clinics
8.4. Veterinary Hospitals
9. Americas Companion Animal Pharmaceuticals Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Companion Animal Pharmaceuticals Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Companion Animal Pharmaceuticals Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Ashish Life Science Pvt. Ltd.
13.2. Boehringer Ingelheim GmbH
13.3. Ceva Santé Animale
13.4. Chanelle Pharma
13.5. Dechra Pharmaceuticals plc
13.6. Eco Animal Health Group plc
13.7. Elanco Animal Health Incorporated
13.8. Endovac Animal Health
13.9. Hipra
13.10. Indian Immunologicals Ltd.
13.11. Inovet
13.12. Kyoritsu Seiyaku
13.13. Lutim Pharma Pvt. Ltd.
13.14. Merck & Co. Inc.
13.15. Norbrook Holdings Limited
13.16. Tianjin Ringpu Bio-Technology Co. Ltd.
13.17. Vetoquinol S.A.
13.18. Virbac
13.19. Zoetis Inc.
13.20. Zydus Animal Health and Investments Limited
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
FIGURE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2026
FIGURE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, 2018-2026 (USD BILLION)
FIGURE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2020 VS 2026 (%)
FIGURE 18. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2026
FIGURE 20. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, 2018-2026 (USD BILLION)
FIGURE 23. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 24. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, 2018-2026 (USD BILLION)
FIGURE 25. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 26. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 27. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 29. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 30. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 31. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, 2018-2026 (USD BILLION)
FIGURE 32. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 33. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2026 (USD BILLION)
FIGURE 34. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 35. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 36. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 37. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 38. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: SCORES
TABLE 49. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: RANKING
TABLE 52. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 53. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 54. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 55. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 56. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 57. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 58. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook